166 related articles for article (PubMed ID: 15470082)
1. Proteochemometric mapping of the interaction of organic compounds with melanocortin receptor subtypes.
Lapinsh M; Veiksina S; Uhlén S; Petrovska R; Mutule I; Mutulis F; Yahorava S; Prusis P; Wikberg JE
Mol Pharmacol; 2005 Jan; 67(1):50-9. PubMed ID: 15470082
[TBL] [Abstract][Full Text] [Related]
2. Proteochemometric modeling reveals the interaction site for Trp9 modified alpha-MSH peptides in melanocortin receptors.
Lapinsh M; Prusis P; Petrovska R; Uhlén S; Mutule I; Veiksina S; Wikberg JE
Proteins; 2007 May; 67(3):653-60. PubMed ID: 17357163
[TBL] [Abstract][Full Text] [Related]
3. QSAR and proteo-chemometric analysis of the interaction of a series of organic compounds with melanocortin receptor subtypes.
Lapinsh M; Prusis P; Mutule I; Mutulis F; Wikberg JE
J Med Chem; 2003 Jun; 46(13):2572-9. PubMed ID: 12801221
[TBL] [Abstract][Full Text] [Related]
4. Cloning, tissue distribution, pharmacology and three-dimensional modelling of melanocortin receptors 4 and 5 in rainbow trout suggest close evolutionary relationship of these subtypes.
Haitina T; Klovins J; Andersson J; Fredriksson R; Lagerström MC; Larhammar D; Larson ET; Schiöth HB
Biochem J; 2004 Jun; 380(Pt 2):475-86. PubMed ID: 14965341
[TBL] [Abstract][Full Text] [Related]
5. Proteochemometric analysis of small cyclic peptides' interaction with wild-type and chimeric melanocortin receptors.
Kontijevskis A; Petrovska R; Mutule I; Uhlen S; Komorowski J; Prusis P; Wikberg JE
Proteins; 2007 Oct; 69(1):83-96. PubMed ID: 17557335
[TBL] [Abstract][Full Text] [Related]
6. Co-operative regulation of ligand binding to melanocortin receptor subtypes: evidence for interacting binding sites.
Kopanchuk S; Veiksina S; Petrovska R; Mutule I; Szardenings M; Rinken A; Wikberg JE
Eur J Pharmacol; 2005 Apr; 512(2-3):85-95. PubMed ID: 15840392
[TBL] [Abstract][Full Text] [Related]
7. Peptoid-peptide hybrids as potent novel melanocortin receptor ligands.
Kruijtzer JA; Nijenhuis WA; Wanders N; Gispen WH; Liskamp RM; Adan RA
J Med Chem; 2005 Jun; 48(13):4224-30. PubMed ID: 15974575
[TBL] [Abstract][Full Text] [Related]
8. Rough set-based proteochemometrics modeling of G-protein-coupled receptor-ligand interactions.
Strömbergsson H; Prusis P; Midelfart H; Lapinsh M; Wikberg JE; Komorowski J
Proteins; 2006 Apr; 63(1):24-34. PubMed ID: 16435365
[TBL] [Abstract][Full Text] [Related]
9. Melanocortin receptors form constitutive homo- and heterodimers.
Mandrika I; Petrovska R; Wikberg J
Biochem Biophys Res Commun; 2005 Jan; 326(2):349-54. PubMed ID: 15582585
[TBL] [Abstract][Full Text] [Related]
10. Proteo-chemometrics analysis of MSH peptide binding to melanocortin receptors.
Prusis P; Lundstedt T; Wikberg JE
Protein Eng; 2002 Apr; 15(4):305-11. PubMed ID: 11983931
[TBL] [Abstract][Full Text] [Related]
11. Aza-scanning of the potent melanocortin receptor agonist Ac-His-D-Phe-Arg-Trp-NH.
Boeglin D; Xiang Z; Sorenson NB; Wood MS; Haskell-Luevano C; Lubell WD
Chem Biol Drug Des; 2006 Apr; 67(4):275-83. PubMed ID: 16629825
[TBL] [Abstract][Full Text] [Related]
12. Structure and function of the potent cyclic and linear melanocortin analogues.
Cho MK; Lee CJ; Lee CH; Li SZ; Lim SK; Baik JH; Lee W
J Struct Biol; 2005 Jun; 150(3):300-8. PubMed ID: 15890278
[TBL] [Abstract][Full Text] [Related]
13. Structural and signaling requirements of the human melanocortin 4 receptor for MAP kinase activation.
Patten CS; Daniels D; Suzuki A; Fluharty SJ; Yee DK
Regul Pept; 2007 Aug; 142(3):111-22. PubMed ID: 17376547
[TBL] [Abstract][Full Text] [Related]
14. Molecular determinants of melanocortin 4 receptor ligand binding and MC4/MC3 receptor selectivity.
Nickolls SA; Cismowski MI; Wang X; Wolff M; Conlon PJ; Maki RA
J Pharmacol Exp Ther; 2003 Mar; 304(3):1217-27. PubMed ID: 12604699
[TBL] [Abstract][Full Text] [Related]
15. Recognition of privileged structures by G-protein coupled receptors.
Bondensgaard K; Ankersen M; Thøgersen H; Hansen BS; Wulff BS; Bywater RP
J Med Chem; 2004 Feb; 47(4):888-99. PubMed ID: 14761190
[TBL] [Abstract][Full Text] [Related]
16. Further evidence for ancient role of ACTH peptides at melanocortin (MC) receptors; pharmacology of dogfish and lamprey peptides at dogfish MC receptors.
Haitina T; Takahashi A; Holmén L; Enberg J; Schiöth HB
Peptides; 2007 Apr; 28(4):798-805. PubMed ID: 17306418
[TBL] [Abstract][Full Text] [Related]
17. Glutamine235 and arginine272 in human melanocortin 5 receptor determines its low affinity to MSH.
Frändberg PA; Xu X; Chhajlani V
Biochem Biophys Res Commun; 1997 Jul; 236(2):489-92. PubMed ID: 9240466
[TBL] [Abstract][Full Text] [Related]
18. QSAR study on melanocortin-4 receptors by support vector machine.
Pourbasheer E; Riahi S; Ganjali MR; Norouzi P
Eur J Med Chem; 2010 Mar; 45(3):1087-93. PubMed ID: 20031282
[TBL] [Abstract][Full Text] [Related]
19. N-terminal fatty acylated His-dPhe-Arg-Trp-NH(2) tetrapeptides: influence of fatty acid chain length on potency and selectivity at the mouse melanocortin receptors and human melanocytes.
Todorovic A; Holder JR; Bauzo RM; Scott JW; Kavanagh R; Abdel-Malek Z; Haskell-Luevano C
J Med Chem; 2005 May; 48(9):3328-36. PubMed ID: 15857138
[TBL] [Abstract][Full Text] [Related]
20. Evidence indicating that the TM4, EL2, and TM5 of the melanocortin 3 receptor Do not participate in ligand binding.
Schiöth HB; Muceniece R; Szardenings M; Prusis P; Wikberg JE
Biochem Biophys Res Commun; 1996 Dec; 229(3):687-92. PubMed ID: 8954958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
